Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Grillot

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
The Journal of Experimental Medicine|May 16, 1998
Transgene expression of bcl-xL permits anti-immunoglobulin (Ig)-induced proliferation in xid B cellsN Solvason, W W Wu, N Kabra, et al.
Genes & Development|August 26, 1998
Selective regulation of Bcl-XL by a Jak kinase-dependent pathway is bypassed in murine hematopoietic malignanciesG Packham, E L White, C M Eischen, et al.
Molecular Endocrinology (Baltimore, Md.)|November 3, 2007
Identification and characterization of a selective peroxisome proliferator-activated receptor beta/delta (NR1C2) antagonistBarry G Shearer, David J Steger, James M Way, et al.
Journal of Medicinal Chemistry|January 25, 2007
Substituted 2-[(4-aminomethyl)phenoxy]-2-methylpropionic acid PPARalpha agonists. 1. Discovery of a novel series of potent HDLc raising agentsMichael L Sierra, Véronique Beneton, Anne-Bénédict Boullay, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
The Journal of Experimental Medicine|May 16, 1998
Transgene expression of bcl-xL permits anti-immunoglobulin (Ig)-induced proliferation in xid B cellsN Solvason, W W Wu, N Kabra, et al.
Genes & Development|August 26, 1998
Selective regulation of Bcl-XL by a Jak kinase-dependent pathway is bypassed in murine hematopoietic malignanciesG Packham, E L White, C M Eischen, et al.
Molecular Endocrinology (Baltimore, Md.)|November 3, 2007
Identification and characterization of a selective peroxisome proliferator-activated receptor beta/delta (NR1C2) antagonistBarry G Shearer, David J Steger, James M Way, et al.
Journal of Medicinal Chemistry|January 25, 2007
Substituted 2-[(4-aminomethyl)phenoxy]-2-methylpropionic acid PPARalpha agonists. 1. Discovery of a novel series of potent HDLc raising agentsMichael L Sierra, Véronique Beneton, Anne-Bénédict Boullay, et al.
Pageof 3